Club 13 Holdings LLC – Trademark Portfolio
Entity Type: 16
Club 13 Holdings LLC holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CLUB13, KAVA JOY, KAVAMOSA, and CLUB 13 13 EST 1999. The owner is based in Hastings, FL.
8165 SR 207 South
Hastings, FL 32145
Showing of trademarks Trademarks
Trademark Classifications
Club 13 Holdings LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Club 13 Holdings LLC have?
Club 13 Holdings LLC has 17 U.S. trademarks filed with the USPTO. Of these, 4 registered, 13 abandoned.
What trademark classes does Club 13 Holdings LLC file in?
Club 13 Holdings LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Club 13 Holdings LLC's most well-known trademarks?
Club 13 Holdings LLC's registered trademark portfolio includes well-known marks such as CLUB13, KAVA JOY, KAVAMOSA, and CLUB 13 13 EST 1999. These are among 4 currently registered trademarks in the portfolio.
What is Club 13 Holdings LLC's trademark registration success rate?
Club 13 Holdings LLC has a 24% trademark registration rate, with 4 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.